We are live on ! Find out more
MURA

Mural Oncology

Delisted

MURA was delisted on the 4th of December, 2025.

86 hedge funds and large institutions have $34.2M invested in Mural Oncology in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 33 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

8.01% less ownership

Funds ownership: 72.43%64.41% (-8%)

15% less funds holding

Funds holding: 10186 (-15)

36% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 33

43% less capital invested

Capital invested by funds: $59.9M → $34.2M (-$25.7M)

56% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 27

68% less call options, than puts

Call options by funds: $6K | Put options by funds: $19K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
86
Holders Change
-15
Holders Change %
-14.85%
% of All Funds
1.24%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
12
Increased
21
Reduced
33
Closed
27
Calls
$6K
Puts
$19K
Net Calls
-$13K
Net Calls Change
-$13K

MURA Hedge Fund Activity: Q2 2024 in Review

86 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q2 2024, worth a combined $34.2M — down 43% from $59.9M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of MURA and 12 opened new positions — a net loss of 15 holders — while 33 trimmed existing stakes and 21 added.

The largest buyer was Solas Capital Management, adding an estimated $1.92M. The largest seller was Westfield Capital Management, cutting an estimated $2.97M.

  • 86 institutional investors held Mural Oncology (MURA) as of Q2 2024, down from 101 in Q1 2024.
  • Funds reported $34.2M of Mural Oncology stock for Q2 2024, down 43% quarter-over-quarter.
  • 12 funds opened new Mural Oncology positions in Q2 2024 and 27 closed out, a net change of -15 holders.
  • The largest Mural Oncology buyer in Q2 2024 was Solas Capital Management, an estimated $1.92M added.
  • The largest Mural Oncology seller in Q2 2024 was Westfield Capital Management, an estimated $2.97M sold.

Based on aggregated 13F filings for Q2 2024.